oxylabs, UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 37,788,775 |
| 1,057,324 |
| 19,606,415 |
| 18,258,932 |
| 510,882 |
| 78.95 |
| 48.32 |
| 17,864,461 |
| 5,283,544 |
| 2,533,183 |
| 20,614,822 |
| 2023 |
|---|
| 44,875,318 |
| 214,039 |
| 7,141,485 |
| 6,633,236 |
| 31,638 |
| 74.13 |
| 14.78 |
| 7,040,837 |
| 7,697,579 |
| 4,690,080 |
| 10,048,336 |
| 2024 |
|---|
| 80,941,075 |
| 355,894 |
| 28,983,460 |
| 26,934,463 |
| 118,430 |
| 64.53 |
| 33.28 |
| 29,475,039 |
| 8,591,332 |
| 3,789,079 |
| 34,277,292 |
Register and
explore Okredo data| 2024 |
|---|
| 80,941,075 |
| 355,894 |
| 28,983,460 |
| 26,934,463 |
| 118,430 |
| 64.53 |
| 33.28 |
| 29,475,039 |
| 8,591,332 |
| 3,789,079 |
| 34,277,292 |
Register and
explore Okredo data2024
Turnover (€)
80,941,075 €
80 % *
Sales per employee (€)
355,894 €66 % *
Profit before tax (€)
28,983,460 €306 % *
Net Profit (€)
26,934,463 €306 % *
Profit per employee (€)
118,430 €274 % *
Total profitability (%)
64.53 %
-12.95 % *
Net profitability (%)
33.28 %125.17 % *
Equity (€)
29,475,039 €319 % *
Amounts Payable And Liabilities (€)
8,591,332 €
12 % *
Non-current Assets (€)
3,789,079 €
-19 % *
CurrentAssets (€)
34,277,292 €241 % *